Literature DB >> 19727884

Comparison of seal oil to tuna oil on plasma lipid levels and blood pressure in hypertriglyceridaemic subjects.

Barbara J Meyer1, A E Lane, N J Mann.   

Abstract

As meat is a rich source of the omega-3 fatty acid docosapentaenoic acid (DPA) and Australians consume six times more meat than fish, investigation of the potential health benefit of DPA is warranted. The aims were to compare the effects of seal oil supplementation with fish oil, on measures of plasma lipids and blood pressure in hypertriglyceridaemic subjects. Forty-eight volunteers were recruited from the Wollongong community and were randomly allocated to one of three groups either receiving 1 g/day of long-chain omega-3 polyunsaturated fatty acids (LC n-3 PUFA) using one of three oils: seal oil capsules (340 mg eicosapentaenoic acid (EPA), 230 mg DPA, 450 mg DHA), fish oil capsules (210 mg EPA, 30 mg DPA, 810 mg DHA) or placebo capsules (containing sunola oil) for 6 weeks. Plasma triglycerides remained unchanged in the placebo group, whilst reductions of 7 and 14% (P < 0.05) were seen in the fish oil and seal oil groups respectively. Systolic blood pressure improved by 8 and 5 mmHg with seal oil and fish oil respectively (P < 0.05). The mean arterial pressure was significantly lower after seal oil supplementation (P < 0.005) compared with the placebo group. These results indicate that seal oil is as effective as fish oil in lowering plasma triglycerides and blood pressure.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19727884     DOI: 10.1007/s11745-009-3333-3

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  34 in total

1.  Persistent changes in the fatty acid composition of erythrocyte membranes after moderate intake of n-3 polyunsaturated fatty acids: study design implications.

Authors:  A J Brown; E Pang; D C Roberts
Journal:  Am J Clin Nutr       Date:  1991-10       Impact factor: 7.045

2.  A comprehensive evaluation of the heparin-manganese precipitation procedure for estimating high density lipoprotein cholesterol.

Authors:  G R Warnick; J J Albers
Journal:  J Lipid Res       Date:  1978-01       Impact factor: 5.922

3.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

4.  Effect of supplementation with dietary seal oil on selected cardiovascular risk factors and hemostatic variables in healthy male subjects.

Authors:  J A Conquer; L A Cheryk; E Chan; P A Gentry; B J Holub
Journal:  Thromb Res       Date:  1999-11-01       Impact factor: 3.944

5.  Dietary intake of long-chain omega-3 polyunsaturated fatty acids: contribution of meat sources.

Authors:  Peter Howe; Barbara Meyer; Sally Record; Katrine Baghurst
Journal:  Nutrition       Date:  2005-11-14       Impact factor: 4.008

6.  Validation of an Australian electronic food frequency questionnaire to measure polyunsaturated fatty acid intake.

Authors:  Monika Swierk; Peter G Williams; Jennifer Wilcox; Kenneth G Russell; Barbara J Meyer
Journal:  Nutrition       Date:  2010-09-24       Impact factor: 4.008

Review 7.  Omega-3 polyunsaturated fatty acid regulation of gene expression.

Authors:  P T Price; C M Nelson; S D Clarke
Journal:  Curr Opin Lipidol       Date:  2000-02       Impact factor: 4.776

8.  Does fish oil lower blood pressure? A meta-analysis of controlled trials.

Authors:  M C Morris; F Sacks; B Rosner
Journal:  Circulation       Date:  1993-08       Impact factor: 29.690

9.  Circulating triacylglycerol and apoE levels in response to EPA and docosahexaenoic acid supplementation in adult human subjects.

Authors:  Richard Buckley; Bethan Shewring; Rufus Turner; Parveen Yaqoob; Anne M Minihane
Journal:  Br J Nutr       Date:  2004-09       Impact factor: 3.718

10.  Very long chain N-3 fatty acids intake and carotid atherosclerosis: an epidemiological study evaluated by ultrasonography.

Authors:  Asuka Hino; Hisashi Adachi; Koji Toyomasu; Noriko Yoshida; Mika Enomoto; Akiko Hiratsuka; Yuji Hirai; Akira Satoh; Tsutomu Imaizumi
Journal:  Atherosclerosis       Date:  2004-09       Impact factor: 5.162

View more
  11 in total

1.  A short-term n-3 DPA supplementation study in humans.

Authors:  Eliza Miller; Gunveen Kaur; Amy Larsen; Su Peng Loh; Kaisa Linderborg; Harrison S Weisinger; Giovanni M Turchini; David Cameron-Smith; Andrew J Sinclair
Journal:  Eur J Nutr       Date:  2012-06-23       Impact factor: 5.614

2.  Dietary polyunsaturated fatty acids and breast cancer risk in Chinese women: a prospective cohort study.

Authors:  Harvey J Murff; Xiao-Ou Shu; Honglan Li; Gong Yang; Xiauyan Wu; Hui Cai; Wanqing Wen; Yu-Tang Gao; Wei Zheng
Journal:  Int J Cancer       Date:  2010-11-23       Impact factor: 7.396

3.  n-3 Docosapentaenoic Acid Intake and Relationship with Plasma Long-Chain n-3 Fatty Acid Concentrations in the United States: NHANES 2003-2014.

Authors:  Chesney K Richter; Karl Stessy Bisselou; Tara M Nordgren; Lynette Smith; Adams Kusi Appiah; Nicholas Hein; Ann Anderson-Berry; Penny Kris-Etherton; Corrine Hanson; Ann C Skulas-Ray
Journal:  Lipids       Date:  2019-04       Impact factor: 1.880

4.  Effects of seal oil and tuna-fish oil on platelet parameters and plasma lipid levels in healthy subjects.

Authors:  Neil J Mann; Stella L O'Connell; Kylie M Baldwin; Indu Singh; Barbara J Meyer
Journal:  Lipids       Date:  2010-07-23       Impact factor: 1.880

5.  Oral docosapentaenoic acid (22:5n-3) is differentially incorporated into phospholipid pools and differentially metabolized to eicosapentaenoic acid in tissues from young rats.

Authors:  Bruce J Holub; Patricia Swidinsky; Eek Park
Journal:  Lipids       Date:  2011-03-06       Impact factor: 1.880

6.  The relevance of serum levels of long chain omega-3 polyunsaturated fatty acids and prostate cancer risk: A meta-analysis.

Authors:  Michael E Chua; Maria Christina D Sio; Mishell C Sorongon; Marcelino L Morales
Journal:  Can Urol Assoc J       Date:  2013 May-Jun       Impact factor: 1.862

7.  Blood level omega-3 Fatty acids as risk determinant molecular biomarker for prostate cancer.

Authors:  Mishell Kris Sorongon-Legaspi; Michael Chua; Maria Christina Sio; Marcelino Morales
Journal:  Prostate Cancer       Date:  2013-03-25

8.  Effects of supplementation with n-3 polyunsaturated fatty acids on cognitive performance and cardiometabolic risk markers in healthy 51 to 72 years old subjects: a randomized controlled cross-over study.

Authors:  Anne Nilsson; Karl Radeborg; Ilkka Salo; Inger Björck
Journal:  Nutr J       Date:  2012-11-22       Impact factor: 3.271

9.  Red Blood Cell Docosapentaenoic Acid (DPA n-3) is Inversely Associated with Triglycerides and C-reactive Protein (CRP) in Healthy Adults and Dose-Dependently Increases Following n-3 Fatty Acid Supplementation.

Authors:  Ann C Skulas-Ray; Michael R Flock; Chesney K Richter; William S Harris; Sheila G West; Penny M Kris-Etherton
Journal:  Nutrients       Date:  2015-08-04       Impact factor: 5.717

10.  Effect of Low Dose Docosahexaenoic Acid-Rich Fish Oil on Plasma Lipids and Lipoproteins in Pre-Menopausal Women: A Dose⁻Response Randomized Placebo-Controlled Trial.

Authors:  Cassandra Sparkes; Robert Gibson; Andrew Sinclair; Paul L Else; Barbara J Meyer
Journal:  Nutrients       Date:  2018-10-08       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.